BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: López-Botet M, Vilches C, Redondo-Pachón D, Muntasell A, Pupuleku A, Yélamos J, Pascual J, Crespo M. Dual Role of Natural Killer Cells on Graft Rejection and Control of Cytomegalovirus Infection in Renal Transplantation. Front Immunol 2017;8:166. [PMID: 28261220 DOI: 10.3389/fimmu.2017.00166] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
Number Citing Articles
1 Abdullah EL, Jalalonmuhali M, Ng KP, Jamaluddin FA, Lim SK. The Role of Lymphocyte Subset in Predicting Allograft Rejections in Kidney Transplant Recipients. Transplant Proc 2022:S0041-1345(22)00065-3. [PMID: 35246329 DOI: 10.1016/j.transproceed.2022.01.009] [Reference Citation Analysis]
2 Farzamikia N, Hejazian SM, Haghi M, Hejazian SS, Zununi Vahed S, Ardalan M. Evaluation of telomeric KIR genes and their association with CMV infection in kidney transplant recipients. Immunogenetics. [DOI: 10.1007/s00251-021-01245-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ataya M, Redondo-Pachón D, Llinàs-Mallol L, Yélamos J, Alari-Pahissa E, Pérez-Sáez MJ, Altadill M, Raïch-Regué D, Vilches C, Pascual J, Crespo M, López-Botet M. Long-Term Evolution of the Adaptive NKG2C+ NK Cell Response to Cytomegalovirus Infection in Kidney Transplantation: An Insight on the Diversity of Host-Pathogen Interaction. J Immunol 2021;207:1882-90. [PMID: 34470855 DOI: 10.4049/jimmunol.2100055] [Reference Citation Analysis]
4 Dębska-Zielkowska J, Moszkowska G, Zieliński M, Zielińska H, Dukat-Mazurek A, Trzonkowski P, Stefańska K. KIR Receptors as Key Regulators of NK Cells Activity in Health and Disease. Cells 2021;10:1777. [PMID: 34359951 DOI: 10.3390/cells10071777] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
5 Duygu B, Olieslagers TI, Groeneweg M, Voorter CEM, Wieten L. HLA Class I Molecules as Immune Checkpoints for NK Cell Alloreactivity and Anti-Viral Immunity in Kidney Transplantation. Front Immunol 2021;12:680480. [PMID: 34295330 DOI: 10.3389/fimmu.2021.680480] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Vietzen H, Rückert T, Hartenberger S, Honsig C, Jaksch P, Geleff S, Hammer Q, Romagnani C, Segura-Wang M, Puchhammer-Stöckl E. Extent of Cytomegalovirus Replication in the Human Host Depends on Variations of the HLA-E/UL40 Axis. mBio 2021;12:e02996-20. [PMID: 33727352 DOI: 10.1128/mBio.02996-20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Nelson CS, Baraniak I, Lilleri D, Reeves MB, Griffiths PD, Permar SR. Immune Correlates of Protection Against Human Cytomegalovirus Acquisition, Replication, and Disease. J Infect Dis 2020;221:S45-59. [PMID: 32134477 DOI: 10.1093/infdis/jiz428] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhu L, Karakizlis H, Weimer R, Morath C, Ekpoom N, Ibrahim EH, Opelz G, Daniel V. Circulating NKG2A-NKG2D+ CD56dimCD16+ Natural Killer (NK) Cells as Mediators of Functional Immunosurveillance in Kidney Transplant Recipients. Ann Transplant 2020;25:e925162. [PMID: 33349627 DOI: 10.12659/AOT.925162] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Vo DN, Constantinides M, Allende-Vega N, Alexia C, Cartron G, Villalba M. Dissecting the NK Cell Population in Hematological Cancers Confirms the Presence of Tumor Cells and Their Impact on NK Population Function. Vaccines (Basel) 2020;8:E727. [PMID: 33276644 DOI: 10.3390/vaccines8040727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gordan S, Albert H, Danzer H, Lux A, Biburger M, Nimmerjahn F. The Immunological Organ Environment Dictates the Molecular and Cellular Pathways of Cytotoxic Antibody Activity. Cell Rep 2019;29:3033-3046.e4. [PMID: 31801071 DOI: 10.1016/j.celrep.2019.10.111] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
11 Shi L, Li W, Liu Y, Chen Z, Hui Y, Hao P, Xu X, Zhang S, Feng H, Zhang B, Zhou S, Li N, Xiao L, Liu L, Ma L, Zhang X. Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted β2m-HLA-G fusion proteins. Stem Cells 2020;38:1423-37. [PMID: 32930470 DOI: 10.1002/stem.3269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Moloudizargari M, Govahi A, Fallah M, Rezvanfar MA, Asghari MH, Abdollahi M. The mechanisms of cellular crosstalk between mesenchymal stem cells and natural killer cells: Therapeutic implications. J Cell Physiol 2021;236:2413-29. [PMID: 32892356 DOI: 10.1002/jcp.30038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
13 Pontrelli P, Rascio F, Castellano G, Grandaliano G, Gesualdo L, Stallone G. The Role of Natural Killer Cells in the Immune Response in Kidney Transplantation. Front Immunol 2020;11:1454. [PMID: 32793200 DOI: 10.3389/fimmu.2020.01454] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
14 Kovacevic Vojtusek I, Burek Kamenaric M, Ivkovic V, Bulimbasic S, Marekovic I, Coric M, Bosnjak Z, Grubic Z, Zunec R. Combined association of recipient killer cell immunoglobulin-like haplotype AA and donor HLA-C*07 gene with BK virus associated nephropathy in kidney transplant patients. HLA 2019;94 Suppl 2:4-10. [PMID: 31361395 DOI: 10.1111/tan.13645] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Quaglia M, Dellepiane S, Guglielmetti G, Merlotti G, Castellano G, Cantaluppi V. Extracellular Vesicles as Mediators of Cellular Crosstalk Between Immune System and Kidney Graft. Front Immunol 2020;11:74. [PMID: 32180768 DOI: 10.3389/fimmu.2020.00074] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
16 Mohebbi A, Mamizadeh Z, Bagheri H, Sharifnezhad F, Tabarraei A, Yazdi M. Prevalent latent human cytomegalovirus genotype b2 in biopsy samples of gastric cancer. Future Virology 2020;15:71-8. [DOI: 10.2217/fvl-2019-0117] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Mbiribindi B, Harden JT, Pena JK, Krams SM. Natural killer cells as modulators of alloimmune responses. Curr Opin Organ Transplant 2019;24:37-41. [PMID: 30480641 DOI: 10.1097/MOT.0000000000000590] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
18 Villalba M, Alexia C, Bellin-Robert A, Fayd'herbe de Maudave A, Gitenay D. Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells. Front Immunol 2019;10:3026. [PMID: 31998309 DOI: 10.3389/fimmu.2019.03026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
19 Kim KH, Yu HT, Hwang I, Park S, Park SH, Kim S, Shin EC. Phenotypic and Functional Analysis of Human NK Cell Subpopulations According to the Expression of FcεRIγ and NKG2C. Front Immunol 2019;10:2865. [PMID: 31867015 DOI: 10.3389/fimmu.2019.02865] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
20 Ataya M, Redondo‐pachón D, Llinàs‐mallol L, Yélamos J, Heredia G, Pérez‐sáez MJ, Vila J, Costa‐garcía M, Raïch‐regué D, Vilches C, Pascual J, Crespo M, López‐botet M. Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients. Am J Transplant 2019;20:663-76. [DOI: 10.1111/ajt.15658] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
21 A Abdullah A, Abdullah R, A Nazariah Z, N Balakrishnan K, Firdaus J Abdullah F, A Bala J, Mohd-Lila MA. Cyclophilin A as a target in the treatment of cytomegalovirus infections. Antivir Chem Chemother 2018;26:2040206618811413. [PMID: 30449131 DOI: 10.1177/2040206618811413] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Xu X, Han Y, Huang H, Bi L, Kong X, Ma X, Shi B, Xiao L. Circulating NK cell subsets and NKT‑like cells in renal transplant recipients with acute T‑cell‑mediated renal allograft rejection. Mol Med Rep 2019;19:4238-48. [PMID: 30942398 DOI: 10.3892/mmr.2019.10091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Pradier A, Papaserafeim M, Li N, Rietveld A, Kaestel C, Gruaz L, Vonarburg C, Spirig R, Puga Yung GL, Seebach JD. Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro. Front Immunol 2019;10:556. [PMID: 30972058 DOI: 10.3389/fimmu.2019.00556] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
24 Artym J, Kocięba M, Zaczyńska E, Kochanowska I, Zimecki M, Kałas W, Strządała L, Zioło E, Jeleń M, Morak-Młodawska B, Pluta K. Prolongation of skin graft survival in mice by an azaphenothiazine derivative. Immunol Lett 2019;208:1-7. [PMID: 30825456 DOI: 10.1016/j.imlet.2019.02.006] [Reference Citation Analysis]
25 Zhu L, Aly M, Wang H, Karakizlis H, Weimer R, Morath C, Kuon RJ, Toth B, Ekpoom N, Opelz G, Daniel V. Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant. Clin Exp Immunol 2018;193:241-54. [PMID: 29679490 DOI: 10.1111/cei.13142] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
26 Zhu L, Aly M, Wang H, Karakizlis H, Weimer R, Morath C, Kuon RJ, Toth B, Ekpoom N, Opelz G, Daniel V. Changes of NK cell subsets with time post-transplant in peripheral blood of renal transplant recipients. Transpl Immunol 2018;49:59-71. [PMID: 29702201 DOI: 10.1016/j.trim.2018.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
27 Vo DN, Alexia C, Allende-Vega N, Morschhauser F, Houot R, Menard C, Tarte K, Cartron G, Villalba M. NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment. Oncoimmunology 2018;7:e1409322. [PMID: 29632722 DOI: 10.1080/2162402X.2017.1409322] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
28 Vietzen H, Pollak K, Honsig C, Jaksch P, Puchhammer-stöckl E. NKG2C Deletion Is a Risk Factor for Human Cytomegalovirus Viremia and Disease After Lung Transplantation. The Journal of Infectious Diseases 2018;217:802-6. [DOI: 10.1093/infdis/jix608] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
29 Muntasell A, Cabo M, Servitja S, Tusquets I, Martínez-García M, Rovira A, Rojo F, Albanell J, López-Botet M. Interplay between Natural Killer Cells and Anti-HER2 Antibodies: Perspectives for Breast Cancer Immunotherapy. Front Immunol 2017;8:1544. [PMID: 29181007 DOI: 10.3389/fimmu.2017.01544] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 6.2] [Reference Citation Analysis]
30 Pupuleku A, Costa-García M, Farré D, Hengel H, Angulo A, Muntasell A, López-Botet M. Elusive Role of the CD94/NKG2C NK Cell Receptor in the Response to Cytomegalovirus: Novel Experimental Observations in a Reporter Cell System. Front Immunol 2017;8:1317. [PMID: 29114247 DOI: 10.3389/fimmu.2017.01317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]